A carregar...

Molecularly Targeted Therapy for Metastatic Colon Cancer: Proven Treatments and Promising New Agents

Treatment algorithms and survival for patients with metastatic colorectal cancer have changed dramatically over the past decade, largely due to the advent of molecularly targeted agents. The lessons we have learned with the integration of bevacizumab and cetuximab/panitumumab into standard therapy i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: El Zouhairi, Majed, Charabaty, Aline, Pishvaian, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: International Society of Gastrointestinal Oncology 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3070284/
https://ncbi.nlm.nih.gov/pubmed/21464866
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!